Search bioRxiv⌕ Search

Biology subjects

Landis, J. T.

Publications and source records attributed to Landis, J. T..

2 recordsLinked to original sources

Efficient and Tidy Manipulation of Annotated Matrix Data with plyxp

Manipulating high-dimensional omics data, such as bulk or single cell gene expression counts matrices, typically requires a bioinformatics analyst to learn domain-specific functions and syntax. These matrix-centric functions and syntax can be less intuitive than working with tidy data analytic principles, as exemplified by tools such as dplyr applied to tabular data. We propose an expressive grammar for manipulating annotated matrix data, with syntax to access, modify, and append matrix data and tabular row and column metadata, including row-wise or columnwise grouped operations. This grammar defines multiple contexts, and providing pronouns for specific recall and assignment within and across these contexts. The plyxp package is an implementation of this grammar for the R/Bioconductor ecosystem, with efficient abstractions for the SummarizedExperiment class. We demonstrate plyxps efficiency compared to alternative approaches on data manipulation tasks requiring computation across contexts.

bioinformatics↗

High-density amplicon sequencing identifies community spread and ongoing evolution of SARS-CoV-2 in the Southern United States

SARS-CoV-2 is constantly evolving. Prior studies have focused on high case-density locations, such as the Northern and Western metropolitan areas in the U.S. This study demonstrates continued SARS-CoV-2 evolution in a suburban Southern U.S. region by high-density amplicon sequencing of symptomatic cases. 57% of strains carried the spike D614G variant. The presence of D614G was associated with a higher genome copy number and its prevalence expanded with time. Four strains carried a deletion in a predicted stem loop of the 3 untranslated region. The data are consistent with community spread within the local population and the larger continental U.S. No strain had mutations in the target sites used in common diagnostic assays. The data instill confidence in the sensitivity of current tests and validate "testing by sequencing" as a new option to uncover cases, particularly those not conforming to the standard clinical presentation of COVID-19. This study contributes to the understanding of COVID-19 by providing an extensive set of genomes from a non-urban setting and further informs vaccine design by defining D614G as a dominant and emergent SARS-CoV-2 isolate in the U.S.

microbiology↗